ArticleJournal of thoracic disease2026

Efficacy of cemiplimab in biomarker defined subgroups of non-small cell lung cancer: a systematic review and meta-analysis.

Yuanyuan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.